Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Neptunus Bioengineering Co., Ltd.
  6. Company
    000078   CNE000000X95

SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD.

(000078)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
Business Summary
Shenzhen Neptunus Bioengineering Co.,Ltd is a China-based company principally engaged in pharmaceutical and food manufacturing and pharmaceutical commercial distribution businesses. The CompanyÔÇÖs main products include anti-tumor products, cardiovascular drugs, marine drugs, respiratory drugs, anti-infective products and other pharmaceuticals, as well as healthcare products, health food and medical instrument. The Company distributes its products mainly in domestic market, with East China as its main market.

Number of employees : 10 484 people.
Sales per Business
20192020Delta
Pharmaceutical Commercial Circulation31 461.9076.1%31 210.5078.2% -0.8%
Medical Devices8 998.3721.8%8 028.2320.1% -10.78%
Pharmaceutical Manufacturing529.231.3%412.741% -22.01%
Health Products and Food321.910.8%283.480.7% -11.94%
Others181.330.4%87.590.2% -51.7%
CNY in Million
Sales per region
20192020Delta
China41 492.70100.3%40 022.50100.3% -3.54%
CNY in Million
Managers
Name Title Age Since
Feng Zhang Vice Chairman & President 48 2019
Da Kai Shen Chief Financial Officer 56 2006
Lai Ping Liu, Dr. Independent Director 51 2016
Yang Gu Independent Director 58 2017
Wei Dong Zhang, Dr. Independent Director 58 2019
Yun Lei Wang Member-Supervisory Board & Securities Rep 50 2020
Wen Liang Zhao Director 46 2019
Members of the board
Name Title Age Since
Si Min Zhang, Dr. Chairman 59 1992
He Huang Chairman-Supervisory Board 53 2019
Zhan Jun Liu, Dr. Vice Chairman 63 2004
Da Kai Shen Chief Financial Officer 56 2006
Feng Zhang Vice Chairman & President 48 2019
Wen Liang Zhao Director 46 2019
Lai Ping Liu, Dr. Independent Director 51 2016
Yang Gu Independent Director 58 2017
Han Shu Che, Dr. Director 54 2019
Wei Dong Zhang, Dr. Independent Director 58 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,750,833,257 1,452,517,717 52.8% 0 0.0% 52.8%
Shareholders
NameEquities%
Si Min Zhang 1,216,445,128 46.4%
Yang Yang 13,803,207 0.53%
China Investment Corp. (Investment Management) 10,394,250 0.40%
China Southern Asset Management Co., Ltd. 8,145,275 0.31%
Yin Suo Sun 5,000,050 0.19%
The Vanguard Group, Inc. 4,841,150 0.18%
Dimensional Fund Advisors LP 4,020,598 0.15%
Xiu Ying Wang 4,000,000 0.15%
Zhu Ping Li 2,783,400 0.11%
Xue Ping He 2,533,850 0.097%
Holdings
NameEquities%Valuation
SHENZHEN NEPTUNUS INTERLONG 1,233,464,500 98.5% 29,270,113 USD
Company contact information
Shenzhen Neptunus Bioengineering Co., Ltd.
24/F, Haiwang Yinhe Invest Mansion
1 Keji Middle 3rd Road
Nanshan District
Shenzhen, Guangdong 518057

Phone : +86.755.26980336
Fax : +86.755.26968995
Web : http://www.neptunus.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Shenzhen Neptunus Bioengineering Co., Ltd.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD.-10.20%1 340
JOHNSON & JOHNSON-0.28%449 095
ROCHE HOLDING AG-6.46%307 637
PFIZER, INC.-9.62%299 559
ABBVIE INC.0.42%240 379
NOVO NORDISK A/S-12.29%219 960
ELI LILLY AND COMPANY-13.89%214 609
MERCK & CO., INC.5.14%203 541
NOVARTIS AG-0.76%191 426
ASTRAZENECA PLC1.82%183 389
BRISTOL-MYERS SQUIBB COMPANY-0.18%141 747
SANOFI7.12%132 839
AMGEN INC.-0.43%126 172
GLAXOSMITHKLINE PLC4.63%113 304
BAYER AG11.87%57 607
CHUGAI PHARMACEUTICAL CO., LTD-4.66%50 722
TAKEDA PHARMACEUTICAL COMPANY LIMITED4.78%44 351
JIANGSU HENGRUI MEDICINE CO., LTD.-19.25%41 130
DAIICHI SANKYO CO., LTD.-15.61%40 987
ASTELLAS PHARMA INC.-0.88%29 758
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-18.94%19 813